Avidity Biosciences, Inc (RNAM) — Free Cash Flow Generation Index

Latest as of December 2023: 0.95x

Avidity Biosciences, Inc (RNAM) has a Free Cash Flow Generation Index of 0.95x as of December 2023. Free cash flow of $15.64 Million represents 1% of operating cash flow ($16.50 Million). See working capital position of Avidity Biosciences, Inc to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.95x
Free Cash Flow / Operating CF

Free Cash Flow

$15.64 Million
USD

Operating Cash Flow

$16.50 Million
USD

Capital Expenditures

$863.00K
USD

Avidity Biosciences, Inc Free Cash Flow Generation Index (2019–2019)

Historical FCF Generation Index trend for Avidity Biosciences, Inc across 1 annual periods. Explore Avidity Biosciences, Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Avidity Biosciences, Inc (2019–2019)

Year-by-year Free Cash Flow Generation Index for Avidity Biosciences, Inc. For the full company profile including market capitalisation, see RNAM market cap.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2019 0.91x $2.25 Million $2.49 Million $235.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).